Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

1
Player Avatar joblock (94.09) Submitted: 12/10/2010 11:33:44 AM : Outperform Start Price: $1.50 ARNA Score: +293.41

They have the safest weight loss drug.

Featured Broker Partners


Advertisement